Onclave Therapeutics Limited

Calculating rank

USPTO Granted Patents = 4

Forward Citations = 16

Loading Chart...

5 inventors (with patents filed for the assignee):

Peter Andrew Seubert (4 out of 14 patents)

Dale Bernard Schenk (4 out of 72 patents)

Jonathan Wall (2 out of 70 patents)

4. Jose William Saldanha (1 out of 49 patents)

5. José W Saldanha (1 out of 10 patents)

4 patents: Sort by Forward Citations

1. 8791243 - Treatment and prophylaxis of amyloidosis (2014-07-29),

2. 8636981 - Detection of amyloid deposits using anti-amyloid antibodies (2014-01-28),

3. 8404815 - Chimeric, humanized, or human antibody 2A4 (2013-03-26),

4. 8268973 - Anti-amyloid antibodies (2012-09-18),

Company Overview

Onclave Therapeutics Limited is a biotechnology company focused on the development of novel cancer therapies. Our mission is to revolutionize the treatment of cancer by targeting the underlying mechanisms of tumor growth and metastasis. Our innovative approach combines cutting-edge research with advanced technology to create targeted therapies that have the potential to significantly improve outcomes for cancer patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#194 in Dublin

#384 in Ireland

Dublin, Ireland